Hepatitis C antibody prevalence in blood donors in different governorates in Egypt.
about
Treatment for cryoglobulinemic and non-cryoglobulinemic peripheral neuropathy associated with hepatitis C virus infectionTreatment for cryoglobulinemic and non-cryoglobulinemic peripheral neuropathy associated with hepatitis C virus infectionFurther evidence for association of hepatitis C infection with parenteral schistosomiasis treatment in Egypt.Monoclonal antibodies: Principles and applications of immmunodiagnosis and immunotherapy for hepatitis C virusBlood transfusion safety in Africa: a literature review of infectious disease and organizational challengesHepatitis C in Egypt - past, present, and futureA systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt.The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesisNecrolytic acral erythema in Egyptian patients with hepatitis C virus infection.Evidence of intense ongoing endemic transmission of hepatitis C virus in EgyptPotential for human immunodeficiency virus parenteral transmission in the Middle East and North Africa: an analysis using hepatitis C virus as a proxy biomarker.Hepatitis C: an epidemiological review.Androgen profiles among Egyptian adults considering liver status.The Core/E1 domain of hepatitis C virus genotype 4a in Egypt does not contain viral mutations or strains specific for hepatocellular carcinoma.Hepatitis C virus infection, Linxian, China.The prevalence of hepatitis C virus in mashhad, iran: a population-based study.A review of chronic hepatitis B epidemiology and management issues in selected countries in the Middle East.Epidemiological characteristics of hepatocellular carcinoma in Egypt: a retrospective analysis of 1313 cases.Efficacy and safety of pegylated interferon in children and adolescents infected with chronic hepatitis C: a preliminary study.High false-negative rate of anti-HCV among Egyptian patients on regular hemodialysis.Hepatic dysfunction in children with acute lymphoblastic leukemia in remission: relation to hepatitis infection.Prevalence of and risk factors for hepatitis C in rural pregnant Egyptian women.Pattern of hepatitis virus infection among pregnant women and their newborns at the Women's Health Center of Assiut University, Upper Egypt.A cross-sectional household cluster serosurvey of hepatitis C virus antibodies in an urban slum of Cairo, Egypt in 2004.Seroepidemiology of TT virus, GBC-C/HGV, and hepatitis viruses B, C, and E among women in a rural area of Tanzania.Post-transfusion hepatitis C seroprevalence in Tanzanian children.Prevalence and mother-to-infant transmission of hepatitis viruses B, C, and E in Southern Tanzania.Hepatitis C virus infection during pregnancy in North India.Immunodetection of a hepatitis C virus (HCV) antigen and Thl/Th2 cytokines in cerebrospinal fluid of meningitis patients.A minipool process for solvent-detergent treatment of cryoprecipitate at blood centres using a disposable bag system.Blood safety begins with safe donations: update among blood donors in Yaounde, Cameroon.Towards hepatitis C virus elimination: Egyptian experience, achievements and limitations
P2860
Q24187162-A4635E03-163B-4FE6-80CD-050524215474Q24201259-46CB4F74-1F0A-4508-A1BA-243158780D1DQ24794127-C876AC55-7C18-4A45-93E3-CDCFE300900DQ26783378-CFD71280-61E0-4E97-9D92-937C0B1DC789Q26866294-C2F8DC1C-E37B-4B47-B86A-885E26F51841Q28354329-C95DED8E-5C48-4FD3-BBDA-308BCD5CD5D9Q30403548-44B4902B-9453-4EC8-AC36-DAF4B49180B9Q30651560-7483780E-A86A-44D2-A468-4025FD314A70Q33249070-4B104ABD-64B3-4ADD-A7C4-40189502E25CQ34093173-748271BD-C972-4EF2-B661-71CBF993A76BQ34255407-3B1C287B-1139-4982-A646-2588A39956A1Q34551348-971B6523-A7B7-4EDB-A93D-9B8443830299Q34764147-99B56FEF-4324-47A7-B6A9-9AB828F37BB7Q35552537-BD34BB23-08DF-4D89-A99C-C6C09D95E6F9Q35804327-26689300-017C-4867-AAF2-2D779C8F6DA3Q36893452-D8ED6DD5-A805-46F9-BD04-2802CB974D3EQ37970382-A11D532E-C4A6-4EF4-A040-00EAB6FB5ECCQ38109962-EEAF89A6-9899-43A7-9F25-D84CB5E1BD10Q38854176-D277745C-8F5F-4FD3-9B03-B5653D0F89C9Q38989981-06439BF4-8E26-45F3-BB6B-67589F90699FQ39242000-0028C45F-EA46-4F19-B0DD-02EFF0A449FCQ39492767-99B2C3C2-C180-4D25-8C52-C34E27E1826DQ39621308-FCB22E0E-D71E-4390-9183-538C3F70301BQ40975333-1F80BE1A-D7AC-4E03-B398-99F08CB8B3E7Q43000942-6E8A16DE-2582-4573-8242-F1709AA1E4D9Q43950670-C2139FED-6EDB-4753-8EAB-600AF4B9E721Q43952185-E4F20291-5E57-4308-8298-74831066131DQ45531117-E626DB89-CA18-4A65-9094-C82B5B53AEFEQ45549650-3A1B4230-5769-4A1B-8D71-D29386497EF4Q45858880-8FFDB862-CDCB-4E86-91F2-46ACD9190E16Q46193304-B698EFA4-B5F2-4A7B-9EBC-892022544BFAQ57815114-C6308FA7-A5E2-43C0-BACC-74C42C249F7B
P2860
Hepatitis C antibody prevalence in blood donors in different governorates in Egypt.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Hepatitis C antibody prevalence in blood donors in different governorates in Egypt.
@en
type
label
Hepatitis C antibody prevalence in blood donors in different governorates in Egypt.
@en
prefLabel
Hepatitis C antibody prevalence in blood donors in different governorates in Egypt.
@en
P2093
P1476
Hepatitis C antibody prevalence in blood donors in different governorates in Egypt.
@en
P2093
Abdallah MY
Hackbart BG
el-Sharkawy MS
P304
P356
10.1016/S0035-9203(97)90070-5
P577
1997-05-01T00:00:00Z